Drug:
Reaction: MALAISE
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25138974 |
GB |
2 | |
Malaise, |
||||
OBETICHOLIC ACID, |
||||
2 | 25139041 |
US |
2 | |
Off label use, Feeling abnormal, Malaise, |
||||
THYROID, PORCINE, LEVOTHYROXINE, |
||||
3 | 25139116 |
GB |
73 | 1 |
Malaise, |
||||
ETANERCEPT, |
||||
4 | 25139394 |
US |
75 | 2 |
Infection, Malaise, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
5 | 25139403 |
DE |
2 | |
Multiple sclerosis pseudo relapse, Nasopharyngitis, Pain in extremity, Sleep disorder, Fatigue, Drug ineffective, Malaise, Lymphocyte count decreased, Immunoglobulins decreased, |
||||
OFATUMUMAB, |
||||
6 | 25139465 |
US |
51 | 2 |
Blood pressure increased, Malaise, |
||||
INSULIN ASPART, |
||||
7 | 25139743 |
US |
45 | 2 |
Vomiting, Diarrhoea, Nausea, Hot flush, COVID-19, Malaise, |
||||
OCRELIZUMAB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, |
||||
8 | 25139937 |
US |
||
Myalgia, Malaise, |
||||
DAPAGLIFLOZIN, |
||||
9 | 25139971 |
GB |
1 | |
Fall, Cerebral haemorrhage, Malaise, Sedation, |
||||
CLOZAPINE, |
||||
10 | 25140053 |
IL |
76 | 1 |
Localised infection, Urinary tract infection, Malaise, Pyrexia, |
||||
11 | 25140195 |
ZA |
71 | |
Cardiac disorder, Malaise, |
||||
DAPAGLIFLOZIN, BISOPROLOL FUMARATE, FUROSEMIDE, ENALAPRIL MALEATE, ENALAPRIL, |
||||
12 | 25140479 |
PR |
61 | 1 |
Bronchitis, Cough, Asthenia, Nasal congestion, Malaise, Off label use, |
||||
LENALIDOMIDE, |
||||
13 | 25140597 |
JP |
64 | 2 |
Malaise, Nausea, Diarrhoea, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
14 | 25140640 |
JP |
||
Platelet count decreased, Malaise, Anaemia, |
||||
PEMBROLIZUMAB, |
||||
15 | 25140677 |
JP |
71 | 2 |
Schizophrenia, Depression, Decreased appetite, Malaise, |
||||
DULAGLUTIDE, |
||||
16 | 25140908 |
GB |
2 | |
Agranulocytosis, Hospitalisation, Malaise, Tooth abscess, White blood cell count decreased, Neutrophil count decreased, |
||||
CLOZAPINE, |
||||
17 | 25141009 |
CA |
68 | 1 |
Urinary tract infection, Intentional product use issue, Malaise, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
18 | 25141050 |
CA |
47 | 2 |
Cardiac failure congestive, Drug hypersensitivity, Nausea, Malaise, Drug ineffective, Diarrhoea, Abdominal discomfort, Abdominal pain upper, Arthralgia, Cough, Rash, Headache, Off label use, Product use issue, Hepatic enzyme increased, Liver disorder, Pain, Cardiac failure, Hypersensitivity, Dyspnoea, Gastrointestinal disorder, Hepatic steatosis, Hypertension, Therapeutic product effect decreased, Contraindicated product administered, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, RANITIDINE, COLCHICINE, PATIROMER, CELECOXIB, CEPHALEXIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LEFLUNOMIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, ENALAPRIL, ETANERCEPT, ALENDRONATE SODIUM, HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOSARTAN, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MOXIFLOXACIN HYDROCHLORIDE, ABATACEPT, PENICILLIN G, HYDROXYCHLOROQUINE SULFATE, ISONIAZID, TOFACITINIB, RITUXIMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, CLARITHROMYCIN, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, IRON SUCROSE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PERINDOPRIL ERBUMINE, PREDNISONE, ATENOLOL, LEVOTHYROXINE, |
||||
19 | 25141123 |
US |
1 | |
Adverse event, Malaise, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
20 | 25141139 |
CA |
89 | 1 |
Malaise, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
21 | 25141377 |
JP |
59 | 2 |
Malignant neoplasm progression, Breast cancer female, Ascites, Pleural effusion, Platelet count decreased, Nausea, Malaise, White blood cell count decreased, Haemoglobin decreased, Dry skin, Product dose omission in error, |
||||
TALAZOPARIB, |
||||
22 | 25141398 |
US |
77 | 2 |
Renal impairment, Blood pressure decreased, Malaise, Blood glucose increased, Vision blurred, Weight increased, Headache, Decreased appetite, Diarrhoea, Cortisol decreased, |
||||
SPIRONOLACTONE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, EMPAGLIFLOZIN, |
||||
23 | 25141564 |
US |
58 | 2 |
Movement disorder, Gait inability, Pain, Malaise, Product use in unapproved indication, |
||||
SARILUMAB, SARILUMAB, INFLIXIMAB-AXXQ, |
||||
24 | 25141709 |
LT |
71 | 1 |
Death, Malaise, |
||||
DAROLUTAMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NEPAFENAC, ALLOPURINOL, RIVAROXABAN, |
||||
25 | 25141717 |
JP |
80 | 2 |
Duodenal ulcer, Weight decreased, Malaise, Decreased appetite, Nausea, Vomiting, |
||||
DONEPEZIL HYDROCHLORIDE, |
||||
26 | 25141872 |
CA |
68 | 2 |
Gastrointestinal haemorrhage, Haemoglobin decreased, Diarrhoea, Frequent bowel movements, Malaise, Abdominal pain, Haemorrhoids, Flatulence, Arthralgia, |
||||
VEDOLIZUMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
27 | 25141918 |
US |
2 | |
Cataract, Abdominal pain lower, Diarrhoea, Anxiety, Sleep disorder, Weight decreased, Coccydynia, Depression, Malaise, Decreased appetite, Abdominal distension, Flatulence, Night sweats, Nausea, Bronchitis, |
||||
VEDOLIZUMAB, |
||||
28 | 25142143 |
US |
76 | 1 |
Dyspnoea, Malaise, Diarrhoea, Nausea, Off label use, |
||||
BOSUTINIB, BOSUTINIB, |
||||
29 | 25142234 |
JP |
8 | 2 |
Malignant neoplasm progression, Pyrexia, Hepatic function abnormal, Malaise, |
||||
PEMBROLIZUMAB, LENVATINIB, LENVATINIB, |
||||
30 | 25142276 |
CA |
2 | |
Loss of consciousness, Malaise, Muscle spasms, Myalgia, Pain in extremity, Sleep disorder, Hyperhidrosis, |
||||
EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, MELOXICAM, MELOXICAM, MELOXICAM, MELOXICAM, MELOXICAM, MELOXICAM, MELOXICAM, MELOXICAM, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
31 | 25142313 |
CA |
45 | 1 |
Blood calcium decreased, Off label use, Therapeutic product effect incomplete, Swelling, Red blood cell count increased, Myalgia, Malaise, Headache, Fatigue, Haemoglobin increased, Dizziness, Diarrhoea, Blood pressure increased, Abdominal pain, Hypoaesthesia, Vitamin D decreased, Ear infection, |
||||
TESTOSTERONE, TESTOSTERONE, TESTOSTERONE,, OCTREOTIDE ACETATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CANDESARTAN, CALCIUM, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, |
||||
32 | 25142329 |
JP |
56 | 2 |
Gallbladder enlargement, C-reactive protein increased, Nausea, Malaise, Hepatic enzyme increased, |
||||
LENVATINIB, LENVATINIB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
33 | 25142576 |
CA |
40 | 2 |
Liver injury, Hepatitis, Lower respiratory tract infection, Pneumonia, Pericarditis, Pemphigus, Finger deformity, Hand deformity, Coeliac disease, Psoriatic arthropathy, Rheumatic fever, Systemic lupus erythematosus, Type 2 diabetes mellitus, Drug-induced liver injury, Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, C-reactive protein increased, Condition aggravated, Confusional state, Drug hypersensitivity, Dyspepsia, Dyspnoea, Fatigue, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rash, Sleep disorder, Stomatitis, Swelling, Synovitis, Taste disorder, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Drug intolerance, Wound infection, Product label confusion, Exposure during pregnancy, Maternal exposure during pregnancy, Off label use, Product quality issue, |
||||
MIRABEGRON, MIRABEGRON, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, THIAMINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN A, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, NAPROXEN, NAPROXEN SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
34 | 25142582 |
FR |
1 | |
Malaise, Cardiac arrest, |
||||
IOMEPROL INJECTION, |
||||
35 | 25142587 |
JP |
78 | 2 |
Cardiomyopathy, Immune-mediated adrenal insufficiency, Myasthenia gravis, Hypochloraemia, Hypoglycaemia, Malaise, Hyponatraemia, |
||||
PEMBROLIZUMAB, |
||||
36 | 25142613 |
GB |
34 | 2 |
Haematemesis, Illness, Apathy, Muscle spasms, Fatigue, Malaise, |
||||
TIRZEPATIDE, |
||||
37 | 25138213 |
US |
45 | 2 |
Feeling abnormal, Malaise, Injection site pain, |
||||
TIRZEPATIDE, |
||||
38 | 25138385 |
US |
80 | 2 |
Malaise, Off label use, |
||||
LENALIDOMIDE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OYSTER SHELL, PANTOPRAZOLE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, |
||||
39 | 25138413 |
US |
60 | 2 |
Dysphagia, Eating disorder, Constipation, Nausea, Malaise, |
||||
IRINOTECAN HYDROCHLORIDE, |
||||
40 | 25138620 |
US |
38 | 2 |
Malaise, Dizziness, |
||||
TRASTUZUMAB-ANNS, |
||||
41 | 25137457 |
US |
61 | 2 |
Malaise, Pain, Dizziness, Dysstasia, Fall, Ankle fracture, Diabetic ketoacidosis, Clostridium difficile infection, Hypotension, |
||||
IBRUTINIB, IBRUTINIB, |
||||
42 | 25137580 |
FR |
57 | 2 |
Sinus tachycardia, Syncope, Somnolence, Malaise, |
||||
CANDESARTAN, OLANZAPINE, OLANZAPINE, AMLODIPINE, FUROSEMIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, |
||||
43 | 25137603 |
FR |
56 | 1 |
Malaise, Somnolence, Loss of consciousness, Muscle spasms, Toxicity to various agents, Drug abuse, |
||||
CANNABIDIOL, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PREGABALIN, |
||||
44 | 25138007 |
US |
2 | |
Malaise, Product dose omission issue, |
||||
BELIMUMAB, |
||||
45 | 25140476 |
65 | 2 | |
Pain, Joint range of motion decreased, Malaise, |
||||
ADALIMUMAB-ATTO, |
||||
46 | 25132141 |
38 | ||
Malaise, Therapy interrupted, Insurance issue, |
||||
SOLRIAMFETOL, BELIMUMAB, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
47 | 25132237 |
RU |
63 | 2 |
Malaise, Asthenia, Dyspnoea, Body temperature increased, Dyspnoea exertional, Pyrexia, Interstitial lung disease, Pleural effusion, Cardiomegaly, Renal cyst, Hepatic cyst, Cough, |
||||
48 | 25132245 |
US |
2 | |
Pneumonia, Malaise, Dyspnoea, Chest pain, Bronchitis, |
||||
SECUKINUMAB, |
||||
49 | 25132399 |
US |
||
Malaise, Off label use, |
||||
BENRALIZUMAB, |
||||
50 | 25132476 |
US |
6 | 2 |
Malaise, Dizziness, |
||||
OLANZAPINE AND SAMIDORPHAN L-MALATE, |
||||
51 | 25132583 |
CA |
58 | 2 |
Full blood count decreased, Malaise, Neutropenia, Dizziness, Headache, |
||||
FULVESTRANT, PALBOCICLIB, PALBOCICLIB, |
||||
52 | 25132763 |
SK |
16 | 1 |
Ileus paralytic, Altered state of consciousness, Malaise, Abdominal distension, Petechiae, Abdominal tenderness, Vomiting, Nausea, Tachypnoea, Blood pressure immeasurable, Pallor, Cyanosis, |
||||
RISPERIDONE, |
||||
53 | 25132828 |
GB |
||
Immobile, Malaise, |
||||
ADALIMUMAB, |
||||
54 | 25132939 |
GB |
71 | 1 |
Blindness, Myocardial infarction, Abdominal discomfort, Malaise, Headache, Nausea, Diarrhoea, Hallucination, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Sleep terror, Transient ischaemic attack, Fatigue, Vomiting, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Subarachnoid haemorrhage, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Angioedema, Chest pain, Palpitations, Tachycardia, Off label use, Intentional product misuse, Pain, Anosmia, Eye pruritus, Facial pain, Abdominal discomfort, Carotid artery occlusion, Back pain, Adverse drug reaction, Abdominal pain upper, Blood glucose increased, Amnesia, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Vasculitis, Intentional product use issue, Pruritus genital, Ventricular tachycardia, |
||||
BISOPROLOL FUMARATE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, NAPROXEN, NAPROXEN SODIUM, SIMVASTATIN, APIXABAN, AMITRIPTYLINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DAPAGLIFLOZIN, DIGOXIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, |
||||
55 | 25133224 |
US |
71 | 2 |
Malaise, Adverse event, Product substitution issue, |
||||
ESTRADIOL, THYROID, PORCINE, |
||||
56 | 25133305 |
US |
2 | |
Malaise, Hot flush, Insomnia, Product substitution issue, |
||||
ESTRADIOL, |
||||
57 | 25133334 |
CA |
70 | 2 |
Diverticulitis, Aortic arteriosclerosis, Enterovesical fistula, Female genital tract fistula, Off label use, Diarrhoea, Discomfort, Gastrointestinal scarring, Malaise, Blood pressure increased, Upper respiratory tract infection, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CEFTRIAXONE, CEFTRIAXONE SODIUM, HYDROMORPHONE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LORAZEPAM, PSYLLIUM HUSK, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PANTOPRAZOLE, SERTRALINE, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ESTRADIOL, VITAMIN A, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, ASCORBIC ACID, |
||||
58 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
59 | 25133703 |
JP |
8 | 2 |
Cerebral infarction, Malignant neoplasm progression, Hypothyroidism, Hypertension, Malaise, |
||||
PEMBROLIZUMAB, |
||||
60 | 25133756 |
CA |
57 | 2 |
Pain, Hypotension, Pain in jaw, Diarrhoea, Headache, Fatigue, Nausea, Pain in extremity, Malaise, Nasopharyngitis, Oropharyngeal pain, Facial pain, Chills, Asthenia, Decreased appetite, Weight decreased, Adverse event, Insomnia, Dizziness, Off label use, |
||||
MACITENTAN, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, TADALAFIL, LEVOTHYROXINE SODIUM, |
||||
61 | 25133818 |
US |
64 | 2 |
Mitral valve incompetence, Irritability, Malaise, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
62 | 25133951 |
US |
3 | 2 |
Malaise, |
||||
ALGLUCOSIDASE ALFA, |
||||
63 | 25134087 |
SE |
48 | 1 |
Dysphagia, Malaise, Fatigue, Decreased appetite, Back pain, Vomiting, Nausea, |
||||
PRETOMANID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, LINEZOLID, |
||||
64 | 25134132 |
CA |
1 | |
Nephrolithiasis, Therapeutic reaction time decreased, Faeces soft, Weight decreased, Diarrhoea, Frequent bowel movements, Defaecation urgency, Mouth ulceration, Malaise, Haemorrhoids, Arthralgia, Back pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, SULFASALAZINE, INFLIXIMAB, AMLODIPINE, LANSOPRAZOLE, BISOPROLOL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
65 | 25134506 |
US |
2 | |
Condition aggravated, Hemiparesis, Pain, Chills, Depressed mood, Pyrexia, Dry throat, Dyspnoea, Malaise, Urinary tract infection, Central nervous system lesion, Insomnia, |
||||
OFATUMUMAB, |
||||
66 | 25134541 |
US |
||
Condition aggravated, Prescription drug used without a prescription, Dizziness, Malaise, Nausea, Asthenia, |
||||
NICOTINE POLACRILEX, |
||||
67 | 25134575 |
CA |
2 | |
Malaise, |
||||
RISANKIZUMAB-RZAA, |
||||
68 | 25134939 |
US |
86 | 2 |
Heart valve replacement, Haemoglobin decreased, Atrial fibrillation, Malaise, |
||||
AMBRISENTAN, MACITENTAN, |
||||
69 | 25134978 |
GB |
74 | 2 |
Osteoporosis, Gastrooesophageal reflux disease, Feeling cold, Pruritus, Malaise, Incorrect dose administered, |
||||
70 | 25135092 |
GR |
1 | |
Malaise, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
71 | 25135148 |
CA |
65 | |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, CANDESARTAN CILEXETIL, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, RAMIPRIL, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, BISOPROLOL FUMARATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERGOCALCIFEROL, DIMENHYDRINATE, DIMENHYDRINATE, IRBESARTAN, IRBESARTAN, IRBESARTAN, SITAGLIPTIN, LEVOTHYROXINE, LEVOTHYROXINE, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PROCHLORPERAZINE, RITUXIMAB, RITUXIMAB, LEVOTHYROXINE SODIUM, ZOLPIDEM TARTRATE, ACITRETIN, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, LEVOTHYROXINE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, INSULIN DETEMIR, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
72 | 25135234 |
CA |
68 | 2 |
Condition aggravated, Contusion, Grip strength decreased, Joint swelling, Osteoarthritis, Rheumatoid arthritis, Spinal stenosis, Tenderness, Treatment failure, Fall, Fatigue, Illness, Malaise, Pain, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, LISINOPRIL, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEVOTHYROXINE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, METHYLPREDNISOLONE ACETATE, GOLD, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, |
||||
73 | 25135275 |
LT |
1 | |
Condition aggravated, Malaise, |
||||
VELPATASVIR AND SOFOSBUVIR, |
||||
74 | 25135388 |
US |
1 | |
Nausea, Malaise, |
||||
TREPROSTINIL, TREPROSTINIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TADALAFIL, ERGOCALCIFEROL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MACITENTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ERGOCALCIFEROL, |
||||
75 | 25135557 |
US |
31 | 2 |
Malaise, Illness, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
76 | 25135599 |
US |
||
Vomiting, Malaise, |
||||
ECULIZUMAB, |
||||
77 | 25135615 |
US |
1 | |
Malaise, Back pain, |
||||
DIMETHYL FUMARATE, |
||||
78 | 25135856 |
US |
75 | 2 |
Dizziness, Dyspnoea, Malaise, |
||||
MEPOLIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, |
||||
79 | 25136241 |
US |
68 | 2 |
Malaise, Pain, Off label use, |
||||
LENALIDOMIDE, |
||||
80 | 25136577 |
ES |
73 | 2 |
Eye operation, Malaise, Off label use, Prescribed overdose, Intentional product use issue, Intentional product misuse, |
||||
CYCLOSPORINE, |
||||
81 | 25136602 |
US |
67 | 1 |
Urinary incontinence, Weight decreased, Decreased appetite, Gastrointestinal disorder, Anxiety, Vomiting, Malaise, Inadequate analgesia, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ENZALUTAMIDE, ENZALUTAMIDE, RELUGOLIX, VALSARTAN AND HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, FERROUS SULFATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AMOXICILLIN, VALSARTAN, ALPRAZOLAM, |
||||
82 | 25136726 |
CA |
76 | 1 |
Drug ineffective, Balance disorder, Dizziness, Erythema, Fall, Immunisation reaction, Influenza, Leukaemia, Malaise, Myasthenia gravis, Nasopharyngitis, Oedema peripheral, Paraesthesia, Syncope, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
83 | 25136758 |
JP |
9 | 2 |
Malignant neoplasm progression, Decreased appetite, Malaise, Gastric ulcer, General physical health deterioration, |
||||
IPILIMUMAB, NIVOLUMAB, |
||||
84 | 25136871 |
US |
81 | 1 |
Loss of consciousness, Malaise, Hypoaesthesia, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
85 | 25136910 |
CA |
75 | 2 |
Malaise, Myalgia, |
||||
FOSINOPRIL, INDAPAMIDE, SERTRALINE, |
||||
86 | 25137075 |
US |
2 | |
Malaise, Abdominal distension, Diarrhoea, Flatulence, Gastrointestinal sounds abnormal, Colitis ulcerative, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
87 | 25137084 |
US |
2 | |
Malaise, Headache, Nausea, Burning sensation, |
||||
GLUCAGON, |
||||
88 | 25140783 |
29 | 1 | |
Malaise, Intentional dose omission, |
||||
BARICITINIB, |
||||
89 | 25126367 |
US |
1 | |
Malaise, |
||||
VENETOCLAX, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACYCLOVIR, LORAZEPAM, OBINUTUZUMAB, ISOSORBIDE DINITRATE, ALPRAZOLAM, ONDANSETRON HYDROCHLORIDE, ATENOLOL, EZETIMIBE, LORATADINE, LORATADINE TABLET, ROSUVASTATIN CALCIUM, PROCHLORPERAZINE MALEATE, LORATADINE, LORATADINE ORAL, ALTEPLASE, |
||||
90 | 25126369 |
US |
2 | |
Malaise, |
||||
ALEMTUZUMAB, |
||||
91 | 25126559 |
CA |
||
Amnesia, Adjustment disorder with depressed mood, Anxiety, Asthenia, Blood cholesterol increased, Breast cancer stage II, Decreased appetite, Delirium, Depression, Dislocation of vertebra, Dry mouth, Dyspepsia, Facet joint syndrome, Fibromyalgia, Gait disturbance, General physical health deterioration, Grip strength decreased, Headache, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Injury, Lip dry, Liver disorder, Liver injury, Lung disorder, Malaise, Memory impairment, Migraine, Muscle spasms, Muscular weakness, Musculoskeletal pain, Night sweats, Obesity, Osteoarthritis, Paraesthesia, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Sciatica, Sleep disorder, Swollen joint count increased, Type 2 diabetes mellitus, Weight decreased, X-ray abnormal, Lupus vulgaris, Wound infection, Medication error, Product use issue, Intentional product use issue, Prescribed overdose, Product use in unapproved indication, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, |
||||
92 | 25126621 |
US |
2 | |
Malaise, |
||||
ERLOTINIB HYDROCHLORIDE, |
||||
93 | 25126635 |
US |
35 | 1 |
Malaise, Vomiting, Nausea, Gastroenteritis viral, |
||||
OFATUMUMAB, |
||||
94 | 25126734 |
US |
87 | 1 |
Malaise, Expired product administered, Product dispensing error, Off label use, Abdominal discomfort, |
||||
APIXABAN, METOPROLOL TARTRATE, METOPROLOL, AMLODIPINE, |
||||
95 | 25127310 |
US |
2 | |
Appendicitis perforated, Malaise, |
||||
LUMATEPERONE, |
||||
96 | 25127327 |
US |
6 | 1 |
Heart rate decreased, Somnolence, Diarrhoea, Headache, Pain, Oxygen saturation decreased, Back pain, Malaise, Chest pain, Constipation, Abdominal distension, |
||||
MACITENTAN, MACITENTAN, |
||||
97 | 25127424 |
US |
62 | 1 |
Malaise, |
||||
APIXABAN, |
||||
98 | 25127463 |
CA |
||
Pneumonia, Chronic obstructive pulmonary disease, Cough, Malaise, |
||||
BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, UMECLIDINIUM, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
99 | 25127491 |
US |
65 | 2 |
Malaise, Diarrhoea, Vomiting, |
||||
TIRZEPATIDE, |
||||
100 | 25127522 |
US |
2 | |
Condition aggravated, General physical health deterioration, Malaise, |
||||
PIMAVANSERIN TARTRATE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28